Improving the Transparency of Prognosis Research: The Role of Reporting, Data Sharing, Registration, and Protocols

1. HemingwayH, CroftP, PerelP, HaydenJA, AbramsK, et al. (2013) Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ 346: e5595.

2. RileyRD, HaydenJA, SteyerbergEW, MoonsKG, AbramsK, et al. (2013) Prognosis research strategy (PROGRESS) 2: prognostic factor research. PLoS Med 10: e1001380.

3. SteyerbergEW, MoonsKG, van der WindtDA, HaydenJA, PerelP, et al. (2013) Prognosis research strategy (PROGRESS) 3: prognostic model research. PLoS Med 10: e1001381.

4. HingoraniAD, WindtDA, RileyRD, AbramsK, MoonsKG, et al. (2013) Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ 346: e5793.

5. RossiD, RasiS, SpinaV, BruscagginA, MontiS, et al. (2013) Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood 121: 1403–1412.

6. RoozenbeekB, LingsmaHF, LeckyFE, LuJ, WeirJ, et al. (2012) Prediction of outcome after moderate and severe traumatic brain injury: External validation of the international mission on prognosis and analysis of clinical trials (IMPACT) and corticoid randomisation after significant head injury (CRASH) prognostic models. Crit Care Med 40: 1609–1617.

7. HillJC, WhitehurstDG, LewisM, BryanS, DunnKM, et al. (2011) Comparison of stratified primary care management for low back pain with current best practice (STarT back): a randomised controlled trial. Lancet 378: 1560–1571.

8. AutierP, BoniolM, La VecchiaC, VattenL, GavinA, et al. (2010) Disparities in breast cancer mortality trends between 30 european countries: retrospective trend analysis of WHO mortality database. BMJ 341: c3620.

9. ChungSC, GedeborgR, NicholasO, JamesS, JeppssonA, et al. (2014) Acute myocardial infarction: A comparison of short-term survival in national outcome registries in Sweden and the UK. Lancet 383 (9925)

10. van StaaTP, LeufkensHG, ZhangB, SmeethL (2009) A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example. PLoS Med 6: e1000194.

11. WienerRS, SchwartzLM, WoloshinS (2011) Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 171: 831–837.

12. PottiA, MukherjeeS, PetersenR, DressmanHK, BildA, et al. (2011) Retraction: a genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006; 355: 570–80 N Engl J Med 364: 1176.

13. Institute of Medicine (IOM) (2012) Evolution of translational omics: lessons learned and the path forward. Available: http://www.iom.edu/Reports/2012/Evolution-of-Translational-Omics.aspx. Accessed 15 April 2014.

14. GewinV (2012) Research: uncovering misconduct. Nature 485: 137–139.

15. HemingwayH, RileyRD, AltmanDG (2009) Ten steps towards improving prognosis research. BMJ 339: b4184.

16. MalatsN, BustosA, NascimentoCM, FernandezF, RivasM, et al. (2005) P53 as a prognostic marker for bladder cancer: a meta-analysis and review. Lancet Oncol 6: 678–686.

17. KyzasPA, Denaxa-KyzaD, IoannidisJP (2007) Almost all articles on cancer prognostic markers report statistically significant results. Eur J Cancer 43: 2559–2579.

18. MallettS, RoystonP, DuttonS, WatersR, AltmanDG (2010) Reporting methods in studies developing prognostic models in cancer: A review. BMC Med 8: 20–7015-8-20.

19. HolmesMV, PerelP, ShahT, HingoraniAD, CasasJP (2011) CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis. JAMA 306: 2704–2714.

20. Dal-ReR, IoannidisJP, BrackenMB, BufflerPA, ChanAW, et al. (2014) Making prospective registration of observational research a reality. Sci Transl Med 6: 224cm1.

21. ChanAW, SongF, VickersA, JeffersonT, DickersinK, et al. (2014) Increasing value and reducing waste: addressing inaccessible research. Lancet 383: 257–266.

22. The PLOS Medicine Editors (2013) Better reporting of scientific studies: why it matters. PLoS Med 10: e1001504.

23. KyzasPA, Denaxa-KyzaD, IoannidisJP (2007) Almost all articles on cancer prognostic markers report statistically significant results. Eur J Cancer 43: 2559–2579.

24. MallettS, RoystonP, DuttonS, WatersR, AltmanDG (2010) Reporting methods in studies developing prognostic models in cancer: A review. BMC Med 8: 20-7015-8-20.

25. BouwmeesterW, ZuithoffNP, MallettS, GeerlingsMI, VergouweY, et al. (2012) Reporting and methods in clinical prediction research: a systematic review. PLoS Med 9: 1–12.

26. Simon R (2001) Evaluating prognostic factor studies. Gospodarowicz MK, Henson DE, Hutter RVP, O'Sullivan B, Sobin LH, et al.., editors. Prognostic factors in cancer. New York: Wiley-Liss. pp. 49–56.

27. VandenbrouckeJP (2010) Preregistration of epidemiologic studies: an ill-founded mix of ideas. Epidemiology 21: 619–620.

28. McShaneLM, AltmanDG, SauerbreiW, TaubeSE, GionM, et al. (2005) Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 97: 1180–1184.

29. BenchimolEI, LanganS, GuttmannA (2013) RECORD Steering Committee (2013) Call to RECORD: the need for complete reporting of research using routinely collected health data. J Clin Epidemiol 66: 703–705.

30. ManolioTA, WeisBK, CowieCC, HooverRN, HudsonK, et al. (2012) New models for large prospective studies: is there a better way? Am J Epidemiol 175: 859–866.

31. DenaxasSC, GeorgeJ, HerrettE, ShahAD, KalraD, et al. (2012) Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol 41: 1625–1638.

32. Lowrance W (2006) Access to collections of data and materials for health research: a report to the medical research council and the wellcome trust. Available: http://www.wellcome.ac.uk/stellent/groups/corporatesite/@msh_grants/documents/web_document/wtx030842.pdf. Accessed 15 April 2014.

33. PiwowarHA, BecichMJ, BilofskyH, CrowleyRS (2008) caBIG Data Sharing and Intellectual Capital Workspace (2008) Towards a data sharing culture: recommendations for leadership from academic health centers. PLoS Med 5: e183.

34. Altman D, Trivella M, Pezzelaa F, Harris AL, Pastorino U (2007) Systematic review of multiple studies of prognosis: the feasibility of obtaining individual patient data. Auget J-L, Balakrishnan N, Mesbah M, Molengberghs G, editors. Advances in statistical methods for the health sciences: applications to cancer and AIDS studies, genome sequence analysis, and survival analysis. Boston: Birkhauser. pp. 3–18.

35. BroezeKA, OpmeerBC, BachmannLM, BroekmansFJ, BossuytPM, et al. (2009) Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine. BMC Med Res Methodol 9: 22-2288-9-22.

36. Abo-ZaidG, SauerbreiW, RileyRD (2012) Individual participant data meta-analysis of prognostic factor studies: state of the art? BMC Med Res Methodol 12: 56-2288-12-56.

37. MarmarouA, LuJ, ButcherI, McHughGS, MushkudianiNA, et al. (2007) IMPACT database of traumatic brain injury: design and description. J Neurotrauma 24: 239–250.

38. LauJ, AntmanEM, Jimenez-SilvaJ, KupelnickB, MostellerF, et al. (1992) Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327: 248–254.

39. RasmussenN, LeeK, BeroL (2009) Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials 10: 116-6215-10-116.

40. LaineC, GoodmanSN, GriswoldME, SoxHC (2007) Reproducible research: moving toward research the public can really trust. Ann Intern Med 146: 450–453.

41. WagerE, WilliamsP (2013) OPEN Project (Overcome failure to Publish nEgative fiNdings) Consortium (2013) “Hardly worth the effort”? medical journals' policies and their editors' and publishers' views on trial registration and publication bias: Quantitative and qualitative study. BMJ 347: f5248.

42. LashTL, VandenbrouckeJP (2012) Should preregistration of epidemiologic study protocols become compulsory? reflections and a counterproposal. Epidemiology 23: 184–188.

43. DickersinK (1990) The existence of publication bias and risk factors for its occurrence. JAMA 263 (10) 1385–1389.

44. WilliamsRJ, TseT, HarlanWR, ZarinDA (2010) Registration of observational studies: is it time? CMAJ 182: 1638–1642.

45. SorensenHT, RothmanKJ (2010) The prognosis for research. BMJ 340: c703.

46. Editors (2010) The registration of observational studies–when metaphors go bad. Epidemiology 21: 607–609.

47. VandenbrouckeJP (2008) Observational research, randomised trials, and two views of medical science. PLoS Med 5: e67.

48. ThomasL, PetersonED (2012) The value of statistical analysis plans in observational research: defining high-quality research from the start. JAMA 308: 773–774.

49. van EnstWA, ScholtenRJ, HooftL (2012) Identification of additional trials in prospective trial registers for Cochrane systematic reviews. PLoS ONE 7: e42812.

50. IoannidisJP (2012) The importance of potential studies that have not existed and registration of observational data sets. JAMA 308: 575–576.

51. BrazmaA, HingampP, QuackenbushJ, SherlockG, SpellmanP, et al. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29: 365–371.

52. Chambers C, Della Salla S (2013) Journal Cortex launches registered reports. Available: http://editorsupdate.elsevier.com/short-communications/journal-cortex-launches-registered-reports/. Accessed 11 June 2014.

53. DickersinK, RennieD (2012) The evolution of trial registries and their use to assess the clinical trial enterprise. JAMA 307: 1861–1864.